Institutional
BML Capital Management, LLC
CIK 0001616824
$155.8M
Reported AUM
16
Positions
Q1 2026
Period
2026-05-06
Filed
The Brief · BML Capital Management, LLC · Q1 2026
AI · grounded in 13F
BML Capital Management, LLC established a new position in TLYS valued at $8.7M. The fund also opened new stakes in KHC for $2.8M and JANX for $2.1M. To fund these moves, the manager closed positions in CVNA with a $2.0M reduction, as well as TSLA and LSTA. Additionally, the fund increased its holding in OM by 250.2%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACRS | ACLARIS THERAPEUTICS INC | $4.34 | -0.46% | 199.31% | -70.93% | $53.4M | 34.31% | — | HELD |
| 2 | AVIR | ATEA PHARMACEUTICALS INC | $4.26 | -2.07% | 31.08% | -82.99% | $38.0M | 24.38% | −431,343 | −5.8% |
| 3 | ORMP | ORAMED PHARMACEUTICALS INC | $3.77 | -1.82% | 89.86% | -71.50% | $10.8M | 6.91% | — | HELD |
| 4 | TLYS | TILLYS INC | $5.10 | -6.42% | 282.50% | -67.03% | $8.7M | 5.59% | +2,150,000 | NEW |
| 5 | OM | OUTSET MED INC | $4.41 | 2.32% | -76.77% | -99.28% | $7.3M | 4.69% | +1,359,021 | +250.2% |
| 6 | PMVP | PMV PHARMACEUTICALS INC | $1.08 | 1.89% | -0.92% | -96.82% | $6.6M | 4.24% | +28,000 | +0.5% |
| 7 | KMX | CARMAX INC | $52.11 | -0.19% | -24.00% | -61.10% | $6.4M | 4.14% | — | HELD |
| 8 | 2KZ0 | KEZAR LIFE SCIENCES INC | — | — | — | — | $5.3M | 3.43% | — | HELD |
| 9 | TIL | INSTIL BIO INC | $7.61 | -3.91% | -72.53% | -97.47% | $5.3M | 3.42% | — | HELD |
| 10 | TGT | TARGET CORP | $133.40 | 0.17% | 45.74% | -40.54% | $4.5M | 2.92% | — | HELD |
| 11 | KHC | KRAFT HEINZ CO | $23.80 | -0.79% | -1.60% | -20.78% | $2.8M | 1.80% | +125,000 | NEW |
| 12 | JANX | JANUX THERAPEUTICS INC | $13.70 | -0.29% | -41.95% | -57.76% | $2.2M | 1.38% | +154,961 | NEW |
| 13 | PLRX | PLIANT THERAPEUTICS INC | $1.19 | 4.39% | -7.03% | -94.11% | $1.9M | 1.25% | — | HELD |
| 14 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $1.99 | -3.40% | 93.20% | -90.96% | $1.1M | 0.69% | — | HELD |
| 15 | IMA | IMAGENEBIO INC | $5.45 | -1.62% | -66.61% | -95.42% | $1.0M | 0.64% | +23,704 | +13.4% |
| 16 | WMT | WALMART INC | $121.03 | 0.17% | 27.23% | 172.06% | $329K | 0.21% | — | HELD |
| 17 | CVNA | CARVANA CO | $70.04 | 1.65% | 10.29% | 4.51% | — | — | −150 | EXITED |
| 18 | TSLA | TESLA INC | $404.66 | -1.58% | 25.66% | 76.71% | — | — | −1,000 | EXITED |
| 19 | LSTA | LISATA THERAPEUTICS INC | $3.49 | 1.16% | 40.73% | -82.51% | — | — | −73,348 | EXITED |
Source: SEC EDGAR · accession 0001754960-26-000359. 13F discloses long positions only — shorts, foreign equities, and options are excluded.